Chief Executive, Pharmaceuticals and Medical Devices Agency (PMDA)
Dr. Yasuhiro Fujiwara has been Chief Executive, PMDA since April 2019. He is a medical oncologist, specializing in breast cancer. He was previously Director-General, Strategic Planning Bureau of the National Cancer Center, and the Deputy Director of the Hospital (Research), National Cancer Center Hospital (NCCH). Before joining NCCH, he was a deputy director of the Evaluation Division II, PMDEC, from 1997 to 2002. PMDEC was a predecessor of PMDA. From 2011 to 2013, he was a Deputy Secretary General of Office of Medical Innovation, Cabinet Secretariat of Japan, and led health policy issues regarding life science.